openPR Logo
Press release

Theranostics Market Size Worth $20.52 Billion by 2026 | Key Industry participants - F Hoffman La Roche, Thermo Fisher Scientific Inc., GE Healthcare, Agilent Technologies

02-11-2019 01:16 PM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Theranostics Market Size Worth $20.52 Billion by 2026 | Key

Theranostics Market Size is anticipated to reach over USD 20.52 Billion by 2026. Theranostics are defined as a combination of diagnostics and drug therapeutics to improve the drug safety, drug restructures development and effectiveness. The combination of effective medical drugs and advanced diagnostic tests has been given numerous names, such as Dx/Rx partnering, integrated medicine, pharmacodiagnostics, and companion diagnostics.

Request for sample report of theranostics market: https://bit.ly/2RQkQRv

The increasing occurrence of life-threatening and chronic diseases and the demand for innovative chemotherapeutic treatments associated with the need for improving disease detection are the key factors propelling the global theranostics market. In addition, the rising potential of clinically adaptable nanomaterials in the biological imaging area and therapy is expected to bolster the market growth. Moreover, improved collaboration between drug and diagnostics firms are anticipated to enhance the growth of the theranostics market. In addition, a decrease in costs and reduced time required for medical trials monitored by pharmaceutical segments are another key drivers propelling the growth of the global theranostics market.

The global Theranostics Market is segmented on the basis of disease type, technology, and geography. On the basis of disease type, the global theranostics market is segmented into Neurological Disorders, Cardiovascular Diseases, Oncology Disorders, and Immunological Disorders. On the basis of disease type, the oncology segment is anticipated to boost the market growth. Increasing cancer cases and theranostics potentials to make effective cancer care are the factors associated with the market growth. On the basis of technology, the global theranostics market is segmented into Polymerase Chain Reaction (PCR), In-situ Hybridization, Immunohistochemistry, and sequencing. In 2017, the PCR is anticipated to dominate the market growth. The existence of a robust evaluate assortment in terms of polymerase chain reaction (PCR) is accountable for the larger market share.

Browse research report on theranostics market: https://bit.ly/2BvE1L7

Theranostics Market Top Key Player:

F Hoffman La Roche
Thermo Fisher Scientific Inc.
GE Healthcare
Agilent Technologies
Qiagen NV
Foundation Medicine
Leica Biosystems Nussloch GmBH
Pfizer, Inc.

About us Polaris Market Research

Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.

Contact us-

Mr. Rohit
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Theranostics Market Size Worth $20.52 Billion by 2026 | Key Industry participants - F Hoffman La Roche, Thermo Fisher Scientific Inc., GE Healthcare, Agilent Technologies here

News-ID: 1576932 • Views:

More Releases from Polaris Market Research & Consulting

Bioactive Ingredients Market 2025 Outlook: Present Scope and Future Industry Opportunities to 2034
Bioactive Ingredients Market 2025 Outlook: Present Scope and Future Industry Opp …
Global Bioactive Ingredients Market is currently valued at USD 65.16 Billion in 2024 and is anticipated to generate an estimated revenue of USD 227.19 Billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 13.3% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034 Polaris Market Research has introduced the latest market research report titled
Point of Care (PoC) diagnostics Market to Expand at 9.40% CAGR, Global Revenue Projected to Exceed USD 137.11 Billion by 2034
Point of Care (PoC) diagnostics Market to Expand at 9.40% CAGR, Global Revenue P …
Polaris Market Research has introduced the latest market research report titled Point of Care (PoC) Diagnostics Market that highlights the major revenue stream for the forecast period. The report contains clear, reliable, and thorough Point of Care (PoC) Diagnostics Market data and information that will undoubtedly help businesses to develop and boost return on investment (ROI). The report focuses on Point of Care (PoC) Diagnostics Market size, share, growth status,
Video Analytics Market Overview: Size, Opportunities, Product Types, and Key Applications
Video Analytics Market Overview: Size, Opportunities, Product Types, and Key App …
Gloval Video Analytics Market is currently valued at USD 12.47 Billion in 2024 and is anticipated to generate an estimated revenue of USD 73.17 Billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 19.38% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034 Polaris Market Research has introduced the latest market research report titled
Food Waste Management Market Set to Reach 69.03 Billion by 2034 with a CAGR of 5.03%
Food Waste Management Market Set to Reach 69.03 Billion by 2034 with a CAGR of 5 …
Polaris Market Research has introduced the latest market research report titled Food Waste Management Market that highlights the major revenue stream for the forecast period. The report contains clear, reliable, and thorough Food Waste Management Market data and information that will undoubtedly help businesses to develop and boost return on investment (ROI). The report focuses on Food Waste Management Market size, share, growth status, future trends, volume, and key market

All 5 Releases


More Releases for Theranostics

Theranostics Market in 2025 Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Theranostics Market -(Product (Diagnostic imaging, Radiopharmaceuticals, Biomarker screening and Software), Application (Prostate Cancer, Bone Metastasis, Other Cancers, Other Application), End-user (Hospitals & Cancer Care Centers, Theranostics Centers, and Research & Academic Centers)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic, the Global Theranostics Market Size is valued
Rising Cancer Prevalence Fuels Growth In The Theranostics Market Driver: Leading …
What combination of drivers is leading to accelerated growth in the theranostics market? The theranostics market is forecasted to grow due to an upward trend in cancer cases. Cancer, a disease characterized by unchecked cell growth affecting numerous organs, is a leading cause of considerable illness and death globally. Theranostics, combining therapeutic and diagnostic aspects, holds significant prospects in managing cancer and chronic illnesses. This methodology paves the way for tailored
Theranostics Market worth $4.3 billion by 2028
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall theranostics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. Theranostics Market [https://www.marketsandmarkets.com/Market-Reports/theranostics-market-111696976.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3
Theranostics Market Worth $4.3 Billion | MarketsandMarkets Trademark
Theranostics Market in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3 billion by 2028, growing at a CAGR of 15.5% from 2023 to 2028 Theranostics Market [https://www.marketsandmarkets.com/Market-Reports/theranostics-market-111696976.html?utm_source=Prnewswire&utm_medium=referral&utm_campaign=paidpr] in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3 billion by 2028, growing at a CAGR of 15.5% from 2023 to 2028 according to
Theranostics Market: Pioneering Precision Medicine into 2030
The Theranostics Market was valued USD 1.9 Billion in 2023 and projected to reach USD 5.4 Billion by 2030, growing at a CAGR of 16.2% during the forecast period of 2024-2030. The Theranostics Market report studies the competitive environment of the Theranostics Market based on company profiles and their efforts to increase product value and production. The Theranostics Market report discusses various factors driving or restraining the market, which will help
01-08-2020 | Health & Medicine
TMR
Theranostics Market Is Booming Worldwide Just Published
Global Theranostics Market: An Overview Theranostics is a new field of medicine which relies on targeted therapies to conduct specific targeted tests. These tests are mainly used for various forms of cancers. The key concern in the therapeutics involve patient centric care with the help of more personalised and precise approach. The technique relies on the use of diagnostic and therapeutic applications to form a single agent. The system is known